Welcome to AFT Pharmaceuticals - International
AFT focuses firmly on the Pharmaceutical Rx and OTC market sectors where it holds considerable expertise. Since its first product launches in 1998, sales have grown every year to be on target to exceed group sales of $80 million this year. AFT operates as a full service pharmaceutical company and also undertakes drug development activities including clinical trials.
AFT has steadily increased its global presence with a growing portfolio of patented and generic pharmaceuticals which are available for licensing. These products are Medsafe and TGA approved providing reassurance for physicians, pharmacists and patients that, in an uncertain world, quality has not been compromised. Current out-licensing agreements span some 40 countries outside Australia and New Zealand.
For International Business Development enquiries please email firstname.lastname@example.org or call +64 9 488 0232.